Internal Medicine, Medical Oncology · Atlanta, GA
NPI
1740398395
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1365 Clifton Rd NE
Atlanta, GA, 30322
Phone (404) 778-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
189 services
Medicare patients, 2024
121
Average age 72
Drug cost, 2024
$2.4M
612 prescriptions
Company payments, 2025
$0
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dong M Shin was code 99215 (office e&m - established), 79 times for 51 patients. In total Dong M Shin billed 189 services in 9 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 79 | 51 | $111.24 | $8,788 |
| 99205 Office E&M - New | Facility | 60 | 60 | $139.19 | $8,352 |
| 99214 Office E&M - Established | Facility | 15 | 12 | $73.08 | $1,096 |
| 99204 Office E&M - New | Facility | 11 | 11 | $107.71 | $1,185 |
By year: 2022 $18K for 162 services; 2023 $23K for 218 services; 2024 $22K for 189 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dong M Shin prescribed most often to Medicare patients was Ondansetron Hcl, with 73 prescriptions and refills. In total Dong M Shin wrote 612 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 73 | 73 | 40 | $607 |
| Dexamethasone Generic | 54 | 55 | 27 | $439 |
| Lenvima Lenvatinib Mesylate | 52 | 52 | Under 11 | $1.2M |
| Oxycodone Hcl Generic | 45 | 45 | 27 | $597 |
| Prochlorperazine Maleate Generic | 43 | 43 | 28 | $306 |
| Cabometyx Cabozantinib S-Malate | 24 | 24 | Under 11 | $600K |
| Levothyroxine Sodium Generic | 20 | 34 | Under 11 | $74.79 |
| Gabapentin Generic | 20 | 22 | Under 11 | $224 |
| Retevmo Selpercatinib | 19 | 19 | Under 11 | $212K |
| Mirtazapine Generic | 17 | 17 | Under 11 | $111 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 14 | 14 | Under 11 | $199 |
| Tafinlar Dabrafenib Mesylate | 12 | 12 | Under 11 | $145K |
| Mekinist Trametinib Dimethyl Sulfoxide | 12 | 12 | Under 11 | $172K |
| Potassium Chloride Generic | 12 | 17 | Under 11 | $616 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 11 | 11 | Under 11 | $81.35 |
Brand drugs: 156 claims; generic drugs: 456 claims; opioid claims: 70.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dong M Shin $0 (- in general payments such as food, travel and fees) from 3 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.